In a study using Mendelian randomization to identify biomarkers for stroke, SCARA5 levels were associated with a decreased risk of SAH, potentially implicating SCARA5 in baseline risk for hemorrhage (385). The gene discussed is SCARA5; the disease is stroke disorder.